Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
Cannara Biotech
Market Cap: CA$166.0m
Engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
LOVE
CA$1.68
7D
0.6%
1Y
40.0%